Clinical Interest of a Genetic Diagnosis in Early Infant Epilepsy, Paraclinical and Therapeutic Management, and Psychological Impact of Families

• Conditions: Early Infant Epilepsy

• Registration Number: NCT05455333
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

To determine the paraclinical and therapeutic interest of genetic diagnosis in early onset epilepsy.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-07-07
• Study First Submitted QC: 2022-07-07
• Study First Posted: 2022-07-13
• Status Verified: 2022-08
• Study Start: 2022-08
• Primary Completion: 2022-08
• Last Update Submitted: 2022-08-11
• Last Update Posted: 2022-08-12
• Study Completion: 2022-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

• Children aged ≤ 12 years,
• hospitalized or followed at the Hautepierre Hospital of the University Hospitals of Strasbourg for primary epilepsy having started in the first 5 months of life, from 2010 to 2021.

Exclusion Criteria

• Children with secondary epilepsy (with infection trauma)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Measurement of event densities	4 month	The frequency of events (crises, going to the emergency room, hospitalizations) before and after genetic diagnosis.

Trial Locations

Locations (1)

Service de Génétique Médicale IGMA - Hôpitaux Universitaires de Strasbourg; 🇫🇷 Strasbourg, France